Recombinant anti-HEL VHH isotype control antibodies (nanobody, single-domain antibody, or the variable domain of heavy chain antibody) good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat...
Recombinant rat IgG2b kappa isotype control and Fc effector silent rat IgG2b kappa isotype control good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. Mouse variable regions...
Recombinant mouse IgG2c kappa isotype control and Fc silenced mutant, mIgG2c LALAPG, good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG2c...
Recombinant mouse IgG2a kappa isotype control and mutants, mIgG2a D265A, N297A, and LALAPG, good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse...
Recombinant mouse IgG2b isotype control and mutants good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG2b isotype controls, including targets, mutants,...
Recombinant mouse IgG3 kappa isotype control for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG3 isotype controls, including targets, mutants, tags, and conjagates.
Recombinant mouse IgG1 kappa isotype control and mIgG1 D265A isotype control mutant for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG1 isotype...
Recombinant human IgG1 bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested.
Recombinant human IgG4 kappa isotype control mutants, hIgG4 S228P and SPLEPG, good for in vivo and in vitro studies. Low or no specific binding to human samples tested. Humanized variable regions and hIgG4 kappa constant regions. The chimeric...
Recombinant rat IgG2a kappa isotype control good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. Mouse variable regions and rat IgG2a kappa constant regions.
